Opconvision: 2025 Independent Directors’ Work Report (Xu Qiang)

Opcon Vision Technology Co., Ltd.

2025 Independent Directors’ Work Report

Dear shareholders and shareholder representatives:

As an independent director of Opcom Vision Technology Co., Ltd. (hereinafter referred to as the "Company"), during my tenure, I strictly followed the provisions and requirements of relevant laws and regulations such as the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Measures for the Administration of Independent Directors of Listed Companies, the Self-Regulatory Guidelines for Listed Companies of the Shenzhen Stock Exchange No. 2 - Standardized Operation of GEM Listed Companies, the Articles of Association, the Appointment and Discussion System of Independent Directors and other relevant laws and regulations. In 2025, During the annual term of office, he performed his duties faithfully, diligently, responsibly and independently, actively attended relevant meetings held by the company, carefully reviewed various proposals of the board of directors, and expressed opinions on various proposals and related matters independently, objectively and impartially, giving full play to the independent and professional role of independent directors. I would like to report on my performance of my duties as an independent director in 2025 as follows:

1. Basic information of independent directors

I am Xu Qiang, male. I graduated from the Department of Physics of Wuhan University from 1979 to 1983 with a Bachelor of Science degree. From August 1983 to December 2017, he served as engineer, office director, engineering department director, assistant to the director in the Hefei General Machinery Research Institute (Institute) of the Ministry of Machinery Industry (belonging to China National Machinery Industry Corporation after August 1999). In 1999, he was appointed as deputy director (and vice president after 2003). In 2015, he concurrently served as vice chairman of SINOMACH General Machinery Technology Co., Ltd. (600444) in 1997. He was rated as a professor-level senior engineer in 2005, received a special government allowance from the State Council in 2005, and was awarded the title of National Outstanding Scientific and Technological Worker in 2016. He has won the first prize of the Science and Technology Progress Award of the Ministry of Electrical and Mechanical Engineering and the second prize of the National Science and Technology Progress Award once each. From January 2018 to May 2021, he served as the executive deputy general manager of the SINOMACH Science and Technology Research Institute and the external director of the Shenyang Instrument Science Research Institute. He currently serves as an external director of SINOMACH, the Sixth Institute of China National Machinery Industry Corporation, China Heavy Machinery Research Institute, China National Machinery Industry Construction Corporation and SINOMACH Asset Management Co., Ltd., and an independent director of the company.

I conducted a self-examination on my independence in 2025, confirmed that I maintain my independence as an independent director, and submitted the self-examination to the board of directors. The board of directors has evaluated my independence and found no circumstances that may affect my independent and objective judgment as an independent director. It believes that I will continue to maintain my independence as an independent director.

2. Annual performance of independent directors’ duties

(1) Attendance at board of directors and shareholders’ meetings

During the reporting period, the company held 8 board meetings and 4 shareholders' meetings. I attended all relevant meetings without being absent or failing to attend the meetings in person twice in a row. In line with the principles of diligence, pragmatism, integrity and responsibility, I took the initiative to understand the status of the matters to be considered at the meeting and obtain the information needed to make decisions before convening the board of directors. I maintained full communication with the company's operating management, actively participated in the discussion of various issues and made reasonable suggestions, and exercised my voting rights with a cautious attitude to safeguard the overall interests of the company and the rights and interests of small and medium-sized shareholders. I believe that during my term of office in 2025, the convening and convening of the company's board of directors and shareholders' meetings complied with legal procedures, and major operating decision-making matters and other major matters have fulfilled relevant procedures and are legal and effective.

During the reporting period, I voted in favor of all the proposals reviewed by the company's board of directors and did not vote against or abstain from voting.

Attendance at the board of directors Attendance at the shareholders' meeting Director's name Position Should attend

Directors who should attend the meeting are absent.

number of meetings times times times times times

Xu Qiang Independent Director of the Fourth Board of Directors 8 8 0 4 4 0

(2) Participation in special committees of the board of directors and special committees of independent directors

During the reporting period, I did not serve as a member of the special committee of the Board of Directors.

During the reporting period, I attended special meetings of independent directors, carefully reviewed matters involving the company's production and operation, financial management, equity incentives, etc., and effectively performed the duties of an independent director, standardized the company's operations, and improved internal controls. The company actively cooperated in providing the information required for me to perform my duties, ensuring the scientificity and objectivity of the decisions made by the independent directors.

During the reporting period, my attendance at meetings was as follows:

Serial number Director’s name Committee Number of times to attend Actual number of times to attend 1 Xu Qiang Special meeting of independent directors 6 6

(3) Exercising the powers of independent directors

During the reporting period, I conducted on-site inspections of the company by participating in the board of directors, shareholders' meetings, etc. to fully understand the company's production and operation, financial management and implementation of internal controls. At the same time, I maintained close contact with other directors, management and relevant staff of the company through phone calls and emails, etc., and kept informed of the progress of the company's major events, grasped the company's production and operation dynamics, and actively and effectively performed the duties of an independent director.

During the reporting period, no matters occurred in the company that required independent directors to exercise special powers.

(3) Communication with the accounting firm

During the reporting period, I actively communicated with the company's internal audit institution and accounting firm, and conscientiously performed relevant responsibilities. During the preparation and disclosure process of the company's periodic reports, I kept abreast of and mastered the work arrangements for each periodic report, actively followed up on the progress of the annual report audit, exchanged opinions with the annual audit accountant on the preliminary audit results, and promptly discussed with the company's management on key issues in the company's operations to ensure that the audit report fully reflects the true situation of the company.

(4) Communicating with investors and safeguarding their legitimate rights and interests

During the reporting period, I actively and effectively performed my duties as an independent director, communicating with shareholders and understanding the demands of small and medium-sized investors by participating in the company's shareholders' meetings and other methods; reading company announcements in a timely manner and actively paying attention to the evaluation of the company by regulatory authorities, the media and the public; paying real-time attention to the impact of industry trends and external market changes on the company's operating conditions; continuing to pay attention to the company's information disclosure work, urging the company to promptly, accurately and completely disclose information in strict accordance with relevant laws and regulations, protecting investors' right to know, and effectively safeguarding the legitimate rights and interests of the company and shareholders.

(5) On-site work at the company

During the reporting period, I actively participated in various meetings such as the company's board of directors and shareholders' meetings, and listened to the introduction of relevant matters by the company's directors, management and staff. In order to fully understand the company's operating conditions, I combined on-site visits, on-site surveys, phone calls, emails, online communications, meetings and other methods to maintain close contact with the company. Contact each other to understand the company's daily operations and standardized operations, and be informed of the company's major issues and progress in a timely manner. I actively participate in discussions and put forward rational suggestions based on my professional knowledge, actively share policy interpretations, macro analysis and market cases, and effectively exert the supervision and guidance functions of independent directors. My working time at the company site in 2025 will be 15 days.

During the reporting period, during my on-site work and performance of my duties, the company attached great importance to and actively cooperated and supported my work, ensuring that sufficient resources and necessary information were obtained when performing corresponding duties, and providing sufficient information rights and good assistance for the effective exercise of the powers of independent directors.

3. Matters of focus in annual performance of duties by independent directors

I strictly abide by the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Code of Governance of Listed Companies, the Measures for the Management of Independent Directors of Listed Companies and other laws and regulations, as well as the Articles of Association, perform my duties faithfully, give full play to the role of independent directors, and safeguard the legitimate rights and interests of the company and all shareholders, especially small and medium shareholders. During the reporting period, the key matters of concern are as follows:

(1) Related transactions that should be disclosed

During the reporting period, the company had no related transactions that met the disclosure standards, and there was no situation that harmed the interests of the company and small and medium-sized shareholders.

(2) Management of raised funds

During the reporting period, I expressed my opinions on the storage and use of raised funds in 2025, cash management of raised funds, project closure of part of the raised funds, change of use of part of the raised funds and use of the project to acquire 75% equity of Suqian Shangyue Qicheng Hospital Management Co., Ltd., and supervised the use of raised funds.

(3) Disclosure of regular reports and internal control evaluation reports

During the reporting period, the company prepared and disclosed the "2024 Annual Report", "2025 First Quarter Report", "2025 Semi-Annual Report" and "2025 Third Quarter Report" on time, accurately disclosed the financial data and important matters during the corresponding reporting period, and fully disclosed the company's operating conditions to investors. I have carefully read the full text of the periodic report. The above reports have been reviewed and approved by the company's board of directors and audit committee. The company's directors and senior managers have all signed written confirmation opinions on the company's periodic report. The company's review and disclosure procedures for periodic reports are legal and compliant, and the financial data are detailed and truly reflect the company's actual situation.

On March 28, 2025, the 14th meeting of the company’s fourth board of directors reviewed and approved the “2024 Internal Control Self-Evaluation Report of Opcon Technology Co., Ltd.” I have inspected the company's internal control and believe that the various internal control systems comply with the relevant laws and regulations of my country and the regulations and requirements of the regulatory authorities, as well as the actual situation of the company's current production and operations. They can effectively ensure the company's standardized operations, prevent and control the company's operating risks, and the internal control system is effectively implemented.

(4) Re-appointment of accounting firm

On December 8, 2025, the company held the 20th meeting of the fourth board of directors, reviewed and approved the "Proposal on Re-appointment of the Accounting Firm", and agreed to continue to appoint Rongcheng Accounting Firm (Special General Partnership) as the company's audit agency for 2025. I believe that Rongcheng Accounting Firm (Special General Partnership) is a financial audit institution that complies with the provisions of the Securities Law of the People's Republic of China. It has provided annual audit services to a number of listed companies and has rich audit experience. In providing audit services to the company, the company objectively, fairly and fairly reflects the company's financial status and operating results, effectively performs the responsibilities of the audit institution, and safeguards the legitimate rights and interests of the company and shareholders from a professional perspective. In terms of professional competence, investor protection ability, integrity status, independence, etc., it can meet the company's requirements for an audit institution. The company's appointment of it as the company's audit institution will not harm the interests of the company and all shareholders.

(5) Remuneration of directors and senior managers

On March 28, 2025, the company held the 14th meeting of the fourth board of directors, which reviewed and approved the "Proposal on the Remuneration Confirmation of the Company's Directors in 2024 and the Remuneration Plan for 2025" and the "Proposal on the Remuneration Confirmation of the Company's Senior Management in 2024 and the Remuneration Plan for 2025". I believe that the remuneration of the company's directors and senior managers is in line with the company's actual operating conditions and the salary levels of the industry and region in which it operates, and the assessment and payment procedures are in compliance with relevant national laws and regulations, the Articles of Association and other relevant provisions.

(6) Equity incentives

During the reporting period, the company adjusted the grant price of the restricted stock incentive plan for 2021, 2023, and 2024 due to the company's implementation of equity distribution and the annual assessment failed to meet the standards and repurchased and canceled the shares. The implementation of the aforementioned incentive plan, adjustment of restricted stock grant prices, repurchase and cancellation of equity incentive shares and other matters have all fulfilled necessary decision-making procedures and information disclosure obligations in accordance with the "Measures for the Administration of Equity Incentives for Listed Companies" and other relevant regulations. Except for the above-mentioned matters, the Company did not have any other matters requiring major attention during the reporting period.

4. Overall evaluation and outlook

During the reporting period, I strictly followed the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Code of Governance of Listed Companies, the Measures for the Administration of Independent Directors of Listed Companies, and other laws and regulations, as well as the provisions of the Articles of Association. I performed my obligations of loyalty and diligence, reviewed the company's proposals, actively participated in the company's decision-making, fully communicated on relevant issues, promoted the company's development and standardized operations, exercised voting rights independently, objectively and prudently, and effectively safeguarded the legitimate rights and interests of the company and investors. I would like to express my sincere gratitude to the company's board of directors, management and relevant personnel for their active and effective cooperation and support in the performance of my duties.

In 2026, I will use my professional knowledge and experience to contribute to the development of the company and provide reference opinions for the scientific decision-making of the board of directors; maintain close communication and cooperation with the company to jointly promote the development of the company; continue to strengthen learning, strictly comply with the provisions and requirements of independent directors in relevant laws and regulations, perform duties conscientiously, diligently and faithfully, and safeguard the legitimate rights and interests of investors, especially small and medium-sized investors.

Hereby report!

Independent Director: Xu Qiang

March 28, 2026